☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Innovent
Innovent Reports Results from the P-II Study of IBI302 for the Treatment of Neovascular Age-related Macular Degeneration (nAMD)
March 19, 2024
Innovent and AnHeart Therapeutics Report the NMPA’s Acceptance of Second NDA for Taletrectinib to Treat Lung Cancer
March 5, 2024
Innovent Reports Updates on the P-I Evaluation of IBI3002 for the Treatment of Asthma
March 1, 2024
Innovent Reports the Acceptance of its NDA by the NMPA for Mazdutide to Treat Overweight or Obese Adults
February 7, 2024
Alvotech Reports Data from the Trial of AVT03 (Biosimilar, Prolia and Xgeva) for Skeletal Diseases
January 29, 2024
Innovent Reports the Result Of Mazdutide (IBI362) in the P-II Study on Chinese Patients with Type-2 Diabetes (T2D)
January 15, 2024
Load more...
Back to Home